|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar
|
|
2
|
Stewart ZA, Westfall MD and Pietenpol JA:
Cell-cycle dysregulation and anticancer therapy. Trends Pharmacol
Sci. 24:139–145. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huang WW, Ko SW, Tsai HY, et al:
Cantharidin induces G2/M phase arrest and apoptosis in human
colorectal cancer colo 205 cells through inhibition of CDK1
activity and caspase-dependent signaling pathways. Int J Oncol.
38:1067–1073. 2011.
|
|
4
|
Visanji JM, Thompson DG and Padfield PJ:
Induction of G2/M phase cell cycle arrest by carnosol and carnosic
acid is associated with alteration of cyclin A and cyclin B1
levels. Cancer Lett. 237:130–136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parker LL and Piwnica-Worms H:
Inactivation of the p34cdc2-cyclin B complex by the human WEE1
tyrosine kinase. Science. 257:1955–1957. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ruiz EJ, Vilar M and Nebreda AR: A
two-step inactivation mechanism of Myt1 ensures CDK1/cyclin B
activation and meiosis I entry. Curr Biol. 20:717–723. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Peng CY, Graves PR, Thoma RS, Wu Z, Shaw
AS and Piwnica-Worms H: Mitotic and G2 checkpoint control:
regulation of 14-3-3 protein binding by phosphorylation of Cdc25C
on serine-216. Science. 277:1501–1505. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ahn J and Prives C: Checkpoint kinase 2
(Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage
regardless of threonine 68 phosphorylation. J Biol Chem.
277:48418–48426. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Turowski P, Franckhauser C, Morris MC,
Vaglio P, Fernandez A and Lamb NJ: Functional cdc25C
dual-specificity phosphatase is required for S-phase entry in human
cells. Mol Biol Cell. 14:2984–2998. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Choi YH, Lee WH, Park KY and Zhang L:
p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin
B1 and G2/M arrest by the isoflavone genistein in human prostate
carcinoma cells. Jpn J Cancer Res. 91:164–173. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rief N, Herges H, Prowald A, Gotz C and
Montenarh M: Binding of the growth suppressor p53 protein to the
cell cycle regulator phosphatase cdc25C. Int J Oncol. 17:189–195.
2000.PubMed/NCBI
|
|
12
|
St Clair S, Giono L, Varmeh-Ziaie S, et
al: DNA damage-induced downregulation of Cdc25C is mediated by p53
via two independent mechanisms: one involves direct binding to the
cdc25C promoter. Mol Cell. 16:725–736. 2004.PubMed/NCBI
|
|
13
|
Hirao A, Kong YY, Matsuoka S, et al: DNA
damage-induced activation of p53 by the checkpoint kinase Chk2.
Science. 287:1824–1827. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ye R, Bodero A, Zhou BB, Khanna KK, Lavin
MF and Lees-Miller SP: The plant isoflavenoid genistein activates
p53 and Chk2 in an ATM-dependent manner. J Biol Chem.
276:4828–4833. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Canman CE, Lim DS, Cimprich KA, et al:
Activation of the ATM kinase by ionizing radiation and
phosphorylation of p53. Science. 281:1677–1679. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Banin S, Moyal L, Shieh S, et al: Enhanced
phosphorylation of p53 by ATM in response to DNA damage. Science.
281:1674–1677. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dalal SN, Schweitzer CM, Gan J and
DeCaprio JA: Cytoplasmic localization of human cdc25C during
interphase requires an intact 14-3-3 binding site. Mol Cell Biol.
19:4465–4479. 1999.PubMed/NCBI
|
|
18
|
Graves PR, Lovly CM, Uy GL and
Piwnica-Worms H: Localization of human Cdc25C is regulated both by
nuclear export and 14-3-3 protein binding. Oncogene. 20:1839–1851.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Savitsky PA and Finkel T: Redox regulation
of Cdc25C. J Biol Chem. 277:20535–20540. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bulavin DV, Demidenko ZN, Phillips C,
Moody SA and Fornace AJ Jr: Phosphorylation of Xenopus Cdc25C at
Ser285 interferes with ability to activate a DNA damage replication
checkpoint in pre-midblastula embryos. Cell Cycle. 2:263–266. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Perdiguero E and Nebreda AR: Regulation of
Cdc25C activity during the meiotic G2/M transition. Cell Cycle.
3:733–737. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tyagi A, Singh RP, Agarwal C, Siriwardana
S, Sclafani RA and Agarwal R: Resveratrol causes Cdc2-tyr15
phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central
mechanism for S phase arrest in human ovarian carcinoma Ovcar-3
cells. Carcinogenesis. 26:1978–1987. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zeng S, Luo GQ and Liu DY: The chemotaxis
effect of ampelopsin on the immunocytes. Zhong Yao Cai. 29:260–262.
2006.(In Chinese).
|
|
24
|
He G, Du F, Yang W, Pei G and Zhu Y:
Effects of tengcha flavonoids on scavenging oxygen free radicals
and inhibiting lipid-peroxidation. Zhong Yao Cai. 26:338–340.
2003.(In Chinese).
|
|
25
|
Murakami T, Miyakoshi M, Araho D, et al:
Hepatoprotective activity of tocha, the stems and leaves of
Ampelopsis grossedentata, and ampelopsin. Biofactors. 21:175–178.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ni F, Gong Y, Li L, Abdolmaleky HM and
Zhou JR: Flavonoid ampelopsin inhibits the growth and metastasis of
prostate cancer in vitro and in mice. PLoS One. 7:e388022012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zeng S, Liu D, Ye Y, Wang L and Wang W:
Antitumor effects of ampelopsin on human lung cancer GLC-82
implanted in nude mice. Zhong Yao Cai. 27:842–845. 2004.(In
Chinese).
|
|
28
|
Liu D and Luo M: Study on inhibitory
effect of ampelopsin on melanoma by serologic pharmacological
method. Zhong Yao Cai. 24:348–350. 2001.(In Chinese).
|
|
29
|
Liu DY, Zheng HQ and Luo GQ: Effects of
ampelopsin on invasion and metastasis of B16 mouse melanoma in vivo
and in vitro. Zhongguo Zhong Yao Za Zhi. 28:957–961. 2003.(In
Chinese).
|
|
30
|
Luo GQ, Zeng S and Liu DY: Inhibitory
effects of ampelopsin on angiogenesis. Zhong Yao Cai. 29:146–150.
2006.(In Chinese).
|
|
31
|
Ye J, Zheng Y and Liu D: Reversal effect
and its mechanism of ampelopsin on multidrug resistance in K562/ADR
cells. Zhongguo Zhong Yao Za Zhi. 34:761–765. 2009.(In
Chinese).
|
|
32
|
Nurse P: Universal control mechanism
regulating onset of M-phase. Nature. 344:503–508. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhong ZX, Qin JP, Zhou GF and Chen XF:
Experimental studies of hypoglycemic action on total flavone of
Ampelopsis grossedentata from Guangxi. Zhongguo Zhong Yao Za
Zhi. 27:687–689. 2002.(In Chinese).
|
|
34
|
Lukas J, Bartkova J, Rohde M, Strauss M
and Bartek J: Cyclin D1 is dispensable for G1 control in
retinoblastoma gene-deficient cells independently of cdk4 activity.
Mol Cell Biol. 15:2600–2611. 1995.PubMed/NCBI
|
|
35
|
Wang Z, Xie Y, Zhang L, et al: Migratory
localization of cyclin D2-Cdk4 complex suggests a spatial
regulation of the G1-S transition. Cell Struct Funct. 33:171–183.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Goldstone S, Pavey S, Forrest A, Sinnamon
J and Gabrielli B: Cdc25-dependent activation of cyclin A/cdk2 is
blocked in G2 phase arrested cells independently of ATM/ATR.
Oncogene. 20:921–932. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Galaktionov K, Lee AK, Eckstein J, et al:
CDC25 phosphatases as potential human oncogenes. Science.
269:1575–1577. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Karlsson C, Katich S, Hagting A, Hoffmann
I and Pines J: Cdc25B and Cdc25C differ markedly in their
properties as initiators of mitosis. J Cell Biol. 146:573–584.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li J and Stern DF: Regulation of CHK2 by
DNA-dependent protein kinase. J Biol Chem. 280:12041–12050. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Peng A and Chen PL: NFBD1, like 53BP1, is
an early and redundant transducer mediating Chk2 phosphorylation in
response to DNA damage. J Biol Chem. 278:8873–8876. 2003.
View Article : Google Scholar : PubMed/NCBI
|
